TABLE 3.
Virusa | No. of colonies in soft agarb
|
Growth in liquidc
|
||||||
---|---|---|---|---|---|---|---|---|
Expt 1 | Expt 2 | Expt 3 | Avg | Expt 1 | Expt 2 | Expt 3 | Avg | |
CSV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TW | TMTC | TMTC | TMTC | TMTC | 262,144 | 131,072 | 131,072 | 174,763 |
TM1 | 36 | 79 | 103 | 73 | 64 | 16 | 64 | 48 |
TM2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TM3 | 27 | 0 | 33 | 20 | 32 | 0 | 0 | 11 |
TM4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TM5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TM6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TM7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Helper virus (CSV) or REV-0-based retroviruses expressing v-Rel (REV-TW) or v-Rel dimerization mutants (REV-TM) were used to infect ConA-stimulated splenic lymphocytes.
Infected splenic lymphocytes were plated in soft agar, and colonies were scored microscopically after 10 days.
Infected splenic lymphocytes were serially diluted in 96-well plates, and growth was scored microscopically after 10 days. Transformation efficiency was calculated by multiplying the reciprocal of the highest dilution giving visible growth by the number of wells showing growth in that dilution.